Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Thomas Litman | |||||||
GSE61140 |
Expression data from mouse arthritis tarsal joints
|
15 | Thomas Litman | Mar 01, 2015 | ||||
GSE63107 |
Ingenol mebutate induces profound inflammatory and wound healing responses in uninvolved and actinic keratosis skin
|
30 | Thomas Litman | Mar 31, 2016 | ||||
GSE66989 |
The effect of short-chain fatty acids (SCFAs) on human monocyte-derived dendritic cells (DCs)
|
8 | Thomas Litman | Dec 28, 2015 | ||||
GSE75890 |
Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis
|
31 | Thomas Litman | Mar 08, 2016 | ||||
GSE122934 |
Cutaneous T cell lymphoma (CTCL) treated with antibiotics and followed over time
|
38 | Thomas Litman | Apr 13, 2020 | ||||
GSE133120 |
Transcriptomic analysis of human cancer cell lines treated with the histone deacetylase inhibitor romidepsin
|
57 | Thomas Litman | Apr 29, 2021 | ||||
GSE137218 |
Skin expression data from psoriasis patients treated with secukinumab
|
84 | Thomas Litman | Mar 26, 2021 | ||||
GSE137220 |
Blood expression data from psoriasis patients treated with secukinumab
|
65 | Thomas Litman | Mar 26, 2021 | ||||
GSE137221 |
Skin and blood expression data from psoriasis patients treated with secukinumab
|
149 | Thomas Litman | Mar 26, 2021 | ||||
GSE143382 |
Gene expression in cutaneous T cell lymphoma (CTCL), dermatitis (D), and healthy subjects (HS)
|
128 | Thomas Litman | Jun 16, 2020 | ||||
GSE143383 |
Gene expression analysis of metastatic adrenocortical tumors
|
63 | Thomas Litman | Sep 25, 2020 | ||||
GSE143385 |
microRNA expression analysis of metastatic adrenocortical tumors
|
39 | Thomas Litman | Sep 25, 2020 | ||||
GSE160208 |
Gene expression in the brain of sporadic Creutzfeldt-Jakob disease patients (CJD), and normal controls (CT)
|
47 | Thomas Litman | Jan 08, 2021 | ||||
GSE193128 |
Skin expression data from psoriasis patients treated with the HSP90 inhibitor RGRN-305
|
61 | Thomas Litman | Jan 10, 2022 |